Sankala Group’s Nuvalent NUVL Stock Holding History

Sankala Group’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17	Closed	-$1.65K	–	639
2026 Q1	$1.65K	Hold	17	–	–	﹤0.01%	502
2025 Q4	$1.73K	Buy	+17	New	+$1.68K	﹤0.01%	505

Other funds holding NUVL

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Sankala Group's NUVL Position: Q2 2026 in Review

Sankala Group sold out of Nuvalent (NUVL) in Q2 2026, closing a stake of 17 shares — an estimated $1.65K sold.

Sankala Group first reported a position in NUVL in Q4 2025 and held it in 2 quarters. The position peaked at $1.73K in Q4 2025. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

Sankala Group reported no remaining Nuvalent position as of Q2 2026 after selling out during the quarter.
Sankala Group sold 17 Nuvalent shares in Q2 2026, an estimated $1.65K.
Sankala Group first reported a position in Nuvalent in Q4 2025 and held it in 2 quarters.
Sankala Group's Nuvalent position peaked at $1.73K in Q4 2025.
293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Sankala Group's 13F filing for Q2 2026, filed 18 Aug 2026.